Traditional cardiac troponin assays required serial sampling over 6-12 hours to confidently rule out myocardial infarction. The development of high-sensitivity troponin (hs-cTn) assays, capable of detecting much lower concentrations, opened the possibility of dramatically faster rule-out protocols. Early validation studies demonstrated that hs-cTn could detect myocardial injury within 1-3 hours of presentation, potentially halving emergency department stays for chest pain.

TRAPID-AMI2016Landmark

0/1h algorithm: rule-out sensitivity 99.1%, NPV 99.8%

Annals of emergency medicineProspective diagnostic studyN=1,282

Proof

Landmark RCTs and pivotal trials that established the evidence base

The High-STEACS trial (2018) was a landmark implementation study enrolling 48,282 patients across 10 hospitals. It demonstrated that implementing high-sensitivity troponin testing with an early rule-out pathway reduced myocardial infarction diagnosis rates and subsequent recurrent MI or cardiac death. The RAPID-TnT trial confirmed the safety of a rapid 0/1-hour protocol, showing non-inferiority for 30-day death or MI at just 1.0% in both early-discharge and standard-care groups.

High-STEACS2018Landmark

Implementation of hs-cTnI reduced recurrent MI and cardiac death at 1 year

LancetStepped-wedge cluster RCTN=48,282

RAPID-TnT2019Landmark

30-day death or MI: 1.0% vs 1.0% (non-inferior, p=0.001 for non-inferiority)

CirculationRCTN=3,378

Guidelines

Integration into clinical practice guidelines and recommendations

The ESC 2020 NSTE-ACS guidelines endorsed the 0/1-hour hs-cTn algorithm as a Class I, Level B recommendation for rapid rule-out and rule-in of myocardial infarction. This represented a fundamental shift from the traditional 6-12 hour serial sampling approach to a protocol that could safely identify low-risk patients within one hour of presentation.

ESC 2020 NSTE-ACS Guidelines

Class I, Level B for 0/1h hs-cTn algorithm for rapid rule-out/rule-in

Now

Current standard of care and ongoing research directions

High-sensitivity troponin 0/1-hour and 0/3-hour pathways are now standard of care in most high-income emergency departments. Current research explores single-sample rule-out protocols, integration with point-of-care testing, and optimal pathways in specific populations such as patients with chronic kidney disease or presenting very early after symptom onset.

Landmark Trials in This Story

TRAPID-AMI2016Landmark

Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T

0/1h algorithm: rule-out sensitivity 99.1%, NPV 99.8%

Annals of emergency medicineProspective diagnostic studyN=1,282

High-STEACS2018Landmark

High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial

Implementation of hs-cTnI reduced recurrent MI and cardiac death at 1 year

LancetStepped-wedge cluster RCTN=48,282

RAPID-TnT2019Landmark

A Randomized Trial of a 1-Hour Troponin T Protocol in Suspected Acute Coronary Syndromes: The Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High-Sensitivity Troponin T Study (RAPID-TnT)

30-day death or MI: 1.0% vs 1.0% (non-inferior, p=0.001 for non-inferiority)

CirculationRCTN=3,378

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3M+ peer-reviewed articles.

Ask about this topic Try AttendMe Free

Related Evidence

Emergency Medicine

Chest Pain Risk Stratification

Safe early discharge from the ED

Frequently Asked Questions

How fast can high-sensitivity troponin rule out a heart attack?+

The ESC-endorsed 0/1-hour algorithm allows rule-out within one hour using two hs-cTn measurements (at presentation and at 1 hour). This was validated in the TRAPID-AMI study with 99.1% sensitivity and 99.8% negative predictive value.

What was the High-STEACS trial?+

High-STEACS was a landmark stepped-wedge cluster RCT enrolling 48,282 patients across 10 Scottish hospitals. It showed that implementing high-sensitivity troponin testing with an early rule-out pathway reduced subsequent MI and cardiac death.